Sekar says FCM Global is one of the only fully licensed Colombian cannabis producers where CB2 will support its medical cannabis research and clinical trials. Sekar is in New York presenting at the Piper Jaffray Healthcare Conference.
Full interview: CB2 Insights partners with fully licensed Colombia-based cannabis company
Quick facts: CB2 Insights Inc.
Price: 0.57 CAD
Market Cap: $55.61 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of CB2 Insights Inc. named herein, including the promotion by the Company of CB2 Insights Inc. in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE